HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preclinical gastrointestinal prokinetic efficacy and endocrine effects of the ghrelin mimetic RM-131.

AbstractAIMS:
The 28 amino acid hormone ghrelin, the natural ligand for the growth hormone secretagogue, or ghrelin receptor (GHR), has diverse physiological functions, including a possible role as a gastrointestinal prokinetic. The synthetic ghrelin mimetic RM-131 is in Phase II clinical trials for treatment of diabetic gastroparesis and other gastrointestinal (GI) disorders. We aimed to determine the relative potency of RM-131, when compared to other GI ghrelin mimetics, to predict efficacy and determine the role of RM-131 in models of inflammatory bowel disease.
MAIN METHODS:
We evaluated and compared ghrelin, RM-131 and other synthetic ghrelin mimetics for their prokinetic potency in models of gastrointestinal disorders in the rat and we evaluated the endocrine (rats and dogs) and anti-inflammatory effects (mice) of the ghrelin mimetic RM-131.
KEY FINDINGS:
The pentapeptide RM-131 increased gastric emptying in rodent models of ileus. RM-131 is about 100-fold more potent than human ghrelin and is 600 to 1800-fold more potent, when compared to several investigational ghrelin mimetics tested in clinical trials. RM-131 has anti-inflammatory effects and significantly increases survival and reduces macroscopic markers of tissue damage in a TNBS model of inflammatory bowel disease. RM-131 treatment shows a transient increase in growth hormone levels in Beagle dogs and rats, returning to baseline upon chronic treatment. Significant effects on glucose and insulin are not observed in chronic studies.
SIGNIFICANCE:
RM-131's potency, efficacy and endocrine profile, are promising attributes for the treatment of diverse functional gastrointestinal disorders in humans.
AuthorsLex Van der Ploeg, Haley Laken, Shubh Sharma, Rakesh Datta, Heather Halem, Jesse Dong, Caroline Touvay, Marc Teillot, Patrick Noonan, Lou Tartaglia, Liz Stoner, Bart Henderson, Keith Gottesdiener, Michael Culler
JournalLife sciences (Life Sci) Vol. 109 Issue 1 Pg. 20-9 (Jul 25 2014) ISSN: 1879-0631 [Electronic] Netherlands
PMID24931905 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Anti-Inflammatory Agents
  • Gastrointestinal Agents
  • Ghrelin
  • Growth Hormone
Topics
  • Animals
  • Anti-Inflammatory Agents (chemistry, therapeutic use)
  • Diabetes Complications (drug therapy)
  • Dogs
  • Gastric Emptying (drug effects)
  • Gastrointestinal Agents (chemistry, therapeutic use)
  • Gastrointestinal Diseases (drug therapy)
  • Gastrointestinal Motility (drug effects)
  • Gastroparesis (drug therapy)
  • Ghrelin (chemistry, therapeutic use)
  • Growth Hormone (metabolism)
  • Humans
  • Ileus (drug therapy)
  • Inflammatory Bowel Diseases (drug therapy)
  • Male
  • Mice
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: